Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 184

Similar articles for PubMed (Select 20372087)

1.

Towards new tuberculosis vaccines.

Svenson S, Källenius G, Pawlowski A, Hamasur B.

Hum Vaccin. 2010 Apr;6(4):309-17. Epub 2010 Apr 19. Review.

2.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

Development of new vaccines and diagnostic reagents against tuberculosis.

Mustafa AS.

Mol Immunol. 2002 Sep;39(1-2):113-9. Review.

PMID:
12213334
5.

How could we have better vaccines against tuberculosis?

Giri PK.

Expert Opin Biol Ther. 2008 Nov;8(11):1759-72. doi: 10.1517/14712598.8.11.1759 . Review.

PMID:
18847310
6.

Recent developments in tuberculosis vaccines.

Haile M, Källenius G.

Curr Opin Infect Dis. 2005 Jun;18(3):211-5. Review.

PMID:
15864097
7.

Advances in tuberculosis vaccine strategies.

Skeiky YA, Sadoff JC.

Nat Rev Microbiol. 2006 Jun;4(6):469-76. Review.

PMID:
16710326
8.

Impact of proteomics on anti-Mycobacterium tuberculosis (MTB) vaccine development.

Jagusztyn-Krynicka EK, Roszczenko P, Grabowska A.

Pol J Microbiol. 2009;58(4):281-7. Review.

9.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
10.

The quest for a new vaccine against tuberculosis.

Delogu G, Fadda G.

J Infect Dev Ctries. 2009 Feb 28;3(1):5-15. Review.

11.

Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.

Dietrich J, Doherty TM.

APMIS. 2009 May;117(5-6):440-57. doi: 10.1111/j.1600-0463.2009.02458.x. Review.

PMID:
19400867
12.

Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.

Sierra VG.

Tuberculosis (Edinb). 2006 May-Jul;86(3-4):169-78. Review.

PMID:
16677860
13.

Tuberculosis vaccine development: The development of novel (preclinical) DNA vaccine.

Okada M, Kita Y.

Hum Vaccin. 2010 Apr;6(4):297-308. Epub 2010 Apr 24. Review.

15.

A novel TB vaccine; towards a strategy based on our understanding of BCG failure.

Agger EM, Andersen P.

Vaccine. 2002 Nov 22;21(1-2):7-14. Review.

PMID:
12443657
16.

Tuberculosis: a new vision for the 21st century.

Small PM.

Kekkaku. 2009 Nov;84(11):721-6.

PMID:
19999594
17.

[Epidemiology of tuberculosis: a global, European and Polish perspective].

Jagielski T, Augustynowicz-Kopeć E, Zwolska Z.

Wiad Lek. 2010;63(3):230-46. Review. Polish.

PMID:
21125747
18.

Is intranasal vaccination a feasible solution for tuberculosis?

Giri PK, Khuller GK.

Expert Rev Vaccines. 2008 Nov;7(9):1341-56. doi: 10.1586/14760584.7.9.1341. Review.

PMID:
18980538
19.

Re-emergence of tuberculosis: strategies and treatment.

Kremer L, Besra GS.

Expert Opin Investig Drugs. 2002 Feb;11(2):153-7. Review.

PMID:
11829709
20.

The second Geneva Consensus: Recommendations for novel live TB vaccines.

Walker KB, Brennan MJ, Ho MM, Eskola J, Thiry G, Sadoff J, Dobbelaer R, Grode L, Liu MA, Fruth U, Lambert PH.

Vaccine. 2010 Mar 8;28(11):2259-70. doi: 10.1016/j.vaccine.2009.12.083. Epub 2010 Jan 20. Review.

PMID:
20074686
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk